Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial

We report a first in-depth comparison of immune reconstitution in patients with HIV-related lymphoma following autologous hematopoietic cell transplant (AHCT) recipients (n=37, lymphoma, BEAM conditioning), HIV(-) AHCT recipients (n=30, myeloma, melphalan conditioning) at 56, 180, and 365 days post-...

Full description

Bibliographic Details
Main Authors: Polina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang, Mat Makowski, Elshafa Hassan Ahmed, Sarah Schlotter, Rebecca Pearson, Rhonda Kitzler, Anna Mozhenkova, Jennifer Le-Rademacher, Richard F. Little, Gorgun Akpek, Ernesto Ayala, Steven M. Devine, Lawrence D. Kaplan, Ariela Noy, Uday R. Popat, Jack W. Hsu, Lawrence E. Morris, Adam M. Mendizabal, Amrita Krishnan, William Wachsman, Nita Williams, Nidhi Sharma, Craig C. Hofmeister, Stephen J. Forman, Willis H. Navarro, Joseph C. Alvarnas, Richard F. Ambinder, Gerard Lozanski, Robert A. Baiocchi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
human immunodeficiency virus (HIV)
hematopoeietic stem cell transplantation
Hodgkin lymphoma (HL)
Non-Hodgkin lymphoma
multiple myeloma
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.700045/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.700045/full

Similar Items